GenSight Biologics S.A. (EPA:SIGHT)
France
· Delayed Price · Currency is EUR 0.0803
-0.0003 (-0.37%)
Jun 26, 2026, 5:35 PM CET
GenSight Biologics Employees
GenSight Biologics had 13 employees as of December 31, 2025. The number of employees decreased by 3 or -18.75% compared to the previous year.
Employees
13
Change (1Y)
-3
Growth (1Y)
-18.75%
Revenue / Employee
€50,154
Profits / Employee
€925,846
Market Cap
18.83M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| genOway Société anonyme | 157 |
| Advicenne | 11 |
| Aelis Farma | 16 |
| Poxel | 5 |
| Nicox | 10 |
| NFL Biosciences | 4 |
| Aton | 9 |
| THX Pharma Société Anonyme | 12 |
GenSight Biologics News
- 5 weeks ago - GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026 - Business Wire
- 5 weeks ago - GenSight Biologics to Hold its Combined General Meeting on May 19, 2026 - Business Wire
- 6 weeks ago - GenSight Biologics Announces Publication on Matching-Adjusted Indirect Comparison of Leber Hereditary Optic Neuropathy Treatments - Business Wire
- 2 months ago - GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026 - Business Wire
- 2 months ago - GenSight Biologics Announces the Filing of its 2025 Universal Registration Document - Business Wire
- 2 months ago - GenSight Biologics Reports Cash Position and Revenue from Early Access Program as of March 31, 2026 - Business Wire
- 3 months ago - GenSight Biologics Confirms Definitive Full-Year 2025 Consolidated Financial Results Are in Line with Estimates - Business Wire
- 3 months ago - GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025 - Business Wire